Friday, May 20, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

NEWS

Chinese company to import Pfizer’s Covid-19 pill

chinese-company-to-import-pfizers-covid-19-pill

Chinese company to import Pfizer’s Covid-19 pill

Beijing, March 11 (Prensa Latina) Chinese company Meheco Corp signed an agreement with the US company Pfizer to import and market the Paxlovid pill developed by the latter, the local press reported.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

According to the Global Times newspaper, the agreement stimulated the shares in the Chinese firm’s stock markets, with local observers considering it positive as it expands the treatment options for the disease, just when the country suffers a rise in Omicron strain infections.

The signing took place after China’s drug regulators approved on February 11th the import and use of Paxlovid in order to administer it to adult patients showing moderate and mild symptoms of Covid-19 and at risk of worsening, which includes elderly with diabetes, heart disease and serious lung problems.

The authorities, however, urged the doctors who prescribe the medicine to monitor its interaction with other medications and also to investigate in depth how it acts in the human body.

Paxlovid helps reduce the symptoms of the disease, the risks of hospitalization and death in three days. So far it has been licensed for use in more than 50 countries around the world.

China green-lighted the drug amid severe Omicron outbreaks in almost twenty provinces and in Hong Kong, where the amount of new patients has reached a daily record of 50,000.

pgh/llp/oda/ymr

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.